France next? Available in France under temporary authorization for cohort use (ATUc) for one year, Trogarzo (ibalizumab) is a monoclonal antibody which is indicated in combination with other antiretroviral drugs, in the treatment of HIV infection. 1 multidrug-resistant in adults for whom it is not otherwise possible to establish a suppressive antiretroviral therapy regimen. Today, new data confirms its effectiveness over time.
https://seronet.info/article/vih-trogarzo-est-efficace-sur-la-duree-88945